Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer
Study Acronym: MIST
Study Information
Alliance Study ID: A221701
NCT Study ID (ClinicalTrials.gov): NCT03839940
Alliance Committee: Cancer Control
Disease or Cancer Type: Other Cancer
Alliance Study Chair: Kathryn Ruddy, MD
Status: TERMINATED
Study Description
This phase III trial studies how well dexamethasone works in reducing everolimus-induced oral stomatitis in patients with cancer. Dexamethasone may help to reduce the everolimus-induced oral stomatitis so as to improve quality of life in cancer patients.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information